| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 52 | 2024 | 1499 | 13.690 |
Why?
|
| Aortic Valve Stenosis | 41 | 2024 | 1976 | 9.070 |
Why?
|
| Aortic Valve | 45 | 2024 | 1934 | 7.490 |
Why?
|
| Atherosclerosis | 48 | 2024 | 3480 | 4.660 |
Why?
|
| Heart Valve Diseases | 13 | 2024 | 1077 | 3.760 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 6 | 2018 | 314 | 2.720 |
Why?
|
| Myocytes, Smooth Muscle | 12 | 2023 | 679 | 2.480 |
Why?
|
| Plaque, Atherosclerotic | 21 | 2024 | 1529 | 2.410 |
Why?
|
| Cell-Derived Microparticles | 7 | 2023 | 167 | 2.110 |
Why?
|
| Muscle, Smooth, Vascular | 17 | 2022 | 1495 | 1.990 |
Why?
|
| Rheumatic Heart Disease | 5 | 2024 | 181 | 1.980 |
Why?
|
| Osteogenesis | 13 | 2022 | 1295 | 1.830 |
Why?
|
| Macrophages | 34 | 2024 | 5710 | 1.810 |
Why?
|
| Lipoprotein(a) | 5 | 2023 | 460 | 1.800 |
Why?
|
| Exosomes | 8 | 2023 | 421 | 1.640 |
Why?
|
| Apolipoproteins E | 25 | 2018 | 1445 | 1.630 |
Why?
|
| Mitral Valve Insufficiency | 13 | 2024 | 1437 | 1.540 |
Why?
|
| Mitral Valve | 16 | 2023 | 1512 | 1.390 |
Why?
|
| Proteomics | 12 | 2024 | 3686 | 1.320 |
Why?
|
| Cardiovascular Diseases | 15 | 2024 | 15433 | 1.250 |
Why?
|
| MicroRNAs | 8 | 2024 | 3767 | 1.250 |
Why?
|
| Cardiovascular System | 5 | 2023 | 834 | 1.160 |
Why?
|
| Collagen | 20 | 2024 | 2689 | 1.150 |
Why?
|
| Calgranulin B | 2 | 2020 | 85 | 1.130 |
Why?
|
| Adaptive Immunity | 2 | 2021 | 727 | 1.060 |
Why?
|
| Cells, Cultured | 36 | 2024 | 19270 | 1.040 |
Why?
|
| Arteries | 5 | 2020 | 1123 | 1.040 |
Why?
|
| Heart Valve Prosthesis | 11 | 2024 | 1494 | 1.030 |
Why?
|
| Carotid Artery Diseases | 8 | 2019 | 890 | 1.020 |
Why?
|
| Endothelial Cells | 22 | 2024 | 3518 | 1.010 |
Why?
|
| Heart Valves | 11 | 2023 | 290 | 1.010 |
Why?
|
| Molecular Imaging | 7 | 2019 | 824 | 1.000 |
Why?
|
| Apolipoprotein C-III | 4 | 2021 | 209 | 0.970 |
Why?
|
| Polycarboxylate Cement | 1 | 2024 | 18 | 0.960 |
Why?
|
| Animals | 139 | 2023 | 169600 | 0.950 |
Why?
|
| Collagen Type I | 4 | 2022 | 592 | 0.940 |
Why?
|
| Hyperphosphatemia | 1 | 2024 | 40 | 0.920 |
Why?
|
| Dynamins | 2 | 2021 | 154 | 0.890 |
Why?
|
| Cathepsins | 5 | 2015 | 240 | 0.880 |
Why?
|
| Arteriosclerosis | 7 | 2002 | 1090 | 0.850 |
Why?
|
| Rheumatic Fever | 1 | 2022 | 71 | 0.830 |
Why?
|
| Mitral Valve Prolapse | 3 | 2023 | 229 | 0.820 |
Why?
|
| Thymosin | 1 | 2022 | 47 | 0.820 |
Why?
|
| Extracellular Matrix | 10 | 2020 | 1747 | 0.810 |
Why?
|
| Aortic Diseases | 5 | 2017 | 740 | 0.800 |
Why?
|
| Myocardial Infarction | 24 | 2023 | 11824 | 0.800 |
Why?
|
| Hematopoietic System | 1 | 2021 | 109 | 0.800 |
Why?
|
| Osteoclasts | 2 | 2017 | 725 | 0.790 |
Why?
|
| Carnitine Acyltransferases | 1 | 2020 | 8 | 0.780 |
Why?
|
| Mitochondria, Liver | 1 | 2021 | 190 | 0.760 |
Why?
|
| Women, Working | 1 | 2021 | 87 | 0.750 |
Why?
|
| Tissue Engineering | 15 | 2023 | 1893 | 0.730 |
Why?
|
| Humans | 156 | 2024 | 752741 | 0.720 |
Why?
|
| Quinazolinones | 1 | 2021 | 221 | 0.700 |
Why?
|
| Energy Metabolism | 3 | 2020 | 2908 | 0.700 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 355 | 0.690 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2024 | 2191 | 0.680 |
Why?
|
| Inflammation | 22 | 2024 | 10751 | 0.670 |
Why?
|
| Macrophage Activation | 8 | 2022 | 566 | 0.670 |
Why?
|
| Receptors, LDL | 8 | 2022 | 480 | 0.670 |
Why?
|
| Mice, Knockout | 30 | 2021 | 14596 | 0.660 |
Why?
|
| Aortic Aneurysm | 1 | 2023 | 644 | 0.650 |
Why?
|
| Cell Communication | 5 | 2024 | 1639 | 0.640 |
Why?
|
| Gene Expression Profiling | 7 | 2023 | 9431 | 0.640 |
Why?
|
| Estrogen Receptor alpha | 2 | 2022 | 588 | 0.630 |
Why?
|
| Sheep | 21 | 2023 | 1445 | 0.620 |
Why?
|
| Inflammasomes | 1 | 2023 | 511 | 0.620 |
Why?
|
| Annexin A5 | 3 | 2013 | 104 | 0.610 |
Why?
|
| Coronary Artery Disease | 10 | 2023 | 6565 | 0.610 |
Why?
|
| Protein Precursors | 1 | 2022 | 1154 | 0.600 |
Why?
|
| Extracellular Space | 3 | 2014 | 596 | 0.590 |
Why?
|
| Mice | 72 | 2023 | 81766 | 0.570 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2023 | 700 | 0.570 |
Why?
|
| Chordae Tendineae | 1 | 2016 | 44 | 0.570 |
Why?
|
| Kidney Failure, Chronic | 3 | 2015 | 2499 | 0.560 |
Why?
|
| Elastic Tissue | 1 | 2016 | 65 | 0.560 |
Why?
|
| Research Personnel | 1 | 2021 | 578 | 0.560 |
Why?
|
| Myocarditis | 1 | 2024 | 770 | 0.560 |
Why?
|
| Collagenases | 8 | 2011 | 227 | 0.550 |
Why?
|
| Diphosphonates | 1 | 2021 | 628 | 0.540 |
Why?
|
| Mentors | 1 | 2021 | 639 | 0.540 |
Why?
|
| Fibrosis | 9 | 2023 | 2028 | 0.540 |
Why?
|
| Immune System | 1 | 2021 | 812 | 0.540 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2016 | 647 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4549 | 0.540 |
Why?
|
| Aorta, Abdominal | 2 | 2017 | 641 | 0.530 |
Why?
|
| Endothelium, Vascular | 14 | 2018 | 4459 | 0.530 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 445 | 0.530 |
Why?
|
| Immunity, Innate | 4 | 2022 | 3002 | 0.520 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1142 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 36 | 2021 | 22009 | 0.520 |
Why?
|
| Cholesterol | 5 | 2022 | 2926 | 0.510 |
Why?
|
| Physicians, Women | 1 | 2021 | 496 | 0.510 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 692 | 0.490 |
Why?
|
| Aorta | 9 | 2013 | 2063 | 0.490 |
Why?
|
| Histology | 1 | 2014 | 16 | 0.490 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2015 | 199 | 0.480 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2013 | 36 | 0.470 |
Why?
|
| Computational Biology | 3 | 2022 | 3531 | 0.460 |
Why?
|
| GTP Phosphohydrolases | 1 | 2017 | 521 | 0.460 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 1883 | 0.460 |
Why?
|
| Transcription Factor CHOP | 1 | 2013 | 74 | 0.460 |
Why?
|
| Cell Differentiation | 13 | 2018 | 11553 | 0.460 |
Why?
|
| Pulmonary Valve | 7 | 2023 | 442 | 0.450 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2013 | 83 | 0.450 |
Why?
|
| Bone Resorption | 1 | 2017 | 721 | 0.450 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2013 | 73 | 0.440 |
Why?
|
| Biomedical Research | 3 | 2021 | 3349 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2020 | 1356 | 0.430 |
Why?
|
| Quinolines | 2 | 2015 | 746 | 0.430 |
Why?
|
| eIF-2 Kinase | 1 | 2013 | 153 | 0.430 |
Why?
|
| Gene Expression Regulation | 11 | 2020 | 12054 | 0.430 |
Why?
|
| Fatty Acids | 1 | 2020 | 1788 | 0.430 |
Why?
|
| Calcification, Physiologic | 1 | 2013 | 170 | 0.430 |
Why?
|
| Protein Multimerization | 1 | 2018 | 985 | 0.430 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1087 | 0.430 |
Why?
|
| Acetylglucosamine | 1 | 2014 | 192 | 0.420 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2020 | 1119 | 0.420 |
Why?
|
| Heart Diseases | 2 | 2017 | 2802 | 0.410 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1167 | 0.410 |
Why?
|
| Calcium | 5 | 2017 | 5774 | 0.410 |
Why?
|
| Interferon-gamma | 3 | 2017 | 3220 | 0.410 |
Why?
|
| Stem Cells | 9 | 2016 | 3581 | 0.410 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1221 | 0.400 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1084 | 0.400 |
Why?
|
| Elastin | 6 | 2016 | 305 | 0.390 |
Why?
|
| Spectroscopy, Near-Infrared | 6 | 2011 | 722 | 0.390 |
Why?
|
| Phenotype | 15 | 2021 | 16484 | 0.380 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 992 | 0.380 |
Why?
|
| Inflammation Mediators | 7 | 2021 | 1901 | 0.380 |
Why?
|
| Gene Regulatory Networks | 2 | 2023 | 1708 | 0.380 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 671 | 0.380 |
Why?
|
| Disease Models, Animal | 24 | 2021 | 18174 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 14 | 2016 | 2702 | 0.380 |
Why?
|
| Mitochondria | 2 | 2021 | 3555 | 0.370 |
Why?
|
| Peptide Hydrolases | 4 | 2009 | 633 | 0.370 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 2675 | 0.370 |
Why?
|
| Glycosaminoglycans | 1 | 2013 | 628 | 0.370 |
Why?
|
| Cardiomyopathies | 2 | 2013 | 1895 | 0.360 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3131 | 0.360 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2022 | 714 | 0.360 |
Why?
|
| Bioprosthesis | 7 | 2010 | 598 | 0.360 |
Why?
|
| Signal Transduction | 20 | 2021 | 23512 | 0.360 |
Why?
|
| Vasculitis | 3 | 2011 | 520 | 0.360 |
Why?
|
| PPAR alpha | 2 | 2021 | 179 | 0.360 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2228 | 0.360 |
Why?
|
| Bone Remodeling | 2 | 2011 | 578 | 0.350 |
Why?
|
| Hep G2 Cells | 3 | 2021 | 395 | 0.350 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1514 | 0.350 |
Why?
|
| Phosphates | 3 | 2024 | 782 | 0.350 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2010 | 938 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 2755 | 0.340 |
Why?
|
| Hydrogels | 4 | 2021 | 730 | 0.340 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2022 | 855 | 0.320 |
Why?
|
| Liver | 3 | 2021 | 7538 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 2492 | 0.320 |
Why?
|
| Thromboplastin | 2 | 2001 | 291 | 0.320 |
Why?
|
| Proteome | 3 | 2024 | 1809 | 0.310 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1666 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 4420 | 0.310 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2229 | 0.310 |
Why?
|
| Models, Biological | 5 | 2022 | 9569 | 0.300 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 1812 | 0.300 |
Why?
|
| Adipose Tissue | 2 | 2018 | 3308 | 0.280 |
Why?
|
| Macrophages, Peritoneal | 3 | 2015 | 252 | 0.280 |
Why?
|
| Male | 49 | 2023 | 354311 | 0.270 |
Why?
|
| Peroxidase | 4 | 2011 | 609 | 0.270 |
Why?
|
| Ventricular Remodeling | 7 | 2022 | 1229 | 0.260 |
Why?
|
| Mice, 129 Strain | 2 | 2017 | 383 | 0.260 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2313 | 0.260 |
Why?
|
| France | 2 | 2017 | 515 | 0.260 |
Why?
|
| Lipids | 5 | 2011 | 3326 | 0.260 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2023 | 1542 | 0.250 |
Why?
|
| Polymers | 4 | 2024 | 1625 | 0.250 |
Why?
|
| Rabbits | 11 | 2021 | 4910 | 0.250 |
Why?
|
| Constriction, Pathologic | 3 | 2023 | 1118 | 0.240 |
Why?
|
| RANK Ligand | 2 | 2017 | 325 | 0.230 |
Why?
|
| Cholesterol, Dietary | 3 | 2010 | 232 | 0.230 |
Why?
|
| Myofibroblasts | 2 | 2016 | 218 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1670 | 0.220 |
Why?
|
| Lipoproteins, LDL | 6 | 2022 | 642 | 0.220 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2016 | 1658 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2022 | 1843 | 0.220 |
Why?
|
| Positron-Emission Tomography | 6 | 2019 | 6364 | 0.220 |
Why?
|
| Matrix Metalloproteinase 9 | 6 | 2010 | 641 | 0.210 |
Why?
|
| Tunica Intima | 5 | 2009 | 464 | 0.210 |
Why?
|
| Drug Discovery | 2 | 2021 | 1060 | 0.210 |
Why?
|
| Lymphangiogenesis | 1 | 2024 | 173 | 0.210 |
Why?
|
| Apolipoprotein B-100 | 2 | 2019 | 150 | 0.210 |
Why?
|
| Carotid Arteries | 5 | 2019 | 952 | 0.210 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2020 | 603 | 0.210 |
Why?
|
| Carbocyanines | 4 | 2009 | 173 | 0.210 |
Why?
|
| Metal Nanoparticles | 2 | 2021 | 410 | 0.200 |
Why?
|
| Membrane Proteins | 6 | 2019 | 7941 | 0.200 |
Why?
|
| Diagnostic Imaging | 3 | 2013 | 3511 | 0.200 |
Why?
|
| Secretory Pathway | 1 | 2021 | 52 | 0.200 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 2215 | 0.200 |
Why?
|
| Matrix Metalloproteinases | 3 | 2016 | 394 | 0.200 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2012 | 709 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 3494 | 0.190 |
Why?
|
| Nanoparticles | 6 | 2009 | 1944 | 0.190 |
Why?
|
| Protein Transport | 2 | 2018 | 1984 | 0.190 |
Why?
|
| Adaptation, Physiological | 6 | 2018 | 1303 | 0.190 |
Why?
|
| Heart Defects, Congenital | 2 | 2014 | 4638 | 0.190 |
Why?
|
| Osteoporosis | 1 | 2010 | 1582 | 0.190 |
Why?
|
| Rupture, Spontaneous | 2 | 2019 | 355 | 0.180 |
Why?
|
| Medical Illustration | 1 | 2021 | 134 | 0.180 |
Why?
|
| Hypercholesterolemia | 6 | 2008 | 1159 | 0.180 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2019 | 30 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2020 | 35798 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 170 | 0.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2012 | 3304 | 0.180 |
Why?
|
| Antigens, CD34 | 3 | 2016 | 666 | 0.180 |
Why?
|
| Models, Molecular | 2 | 2022 | 5460 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 4 | 2019 | 1071 | 0.170 |
Why?
|
| Polyesters | 4 | 2023 | 366 | 0.170 |
Why?
|
| Hormones | 1 | 2024 | 896 | 0.170 |
Why?
|
| Monocytes | 5 | 2010 | 2602 | 0.170 |
Why?
|
| Diet, Atherogenic | 4 | 2005 | 96 | 0.170 |
Why?
|
| Retinoids | 1 | 2019 | 100 | 0.170 |
Why?
|
| Chemokine CCL2 | 3 | 2015 | 616 | 0.170 |
Why?
|
| Vascular Grafting | 1 | 2021 | 144 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 6 | 2017 | 2005 | 0.170 |
Why?
|
| Indican | 1 | 2019 | 16 | 0.170 |
Why?
|
| Antigens, Ly | 3 | 2010 | 292 | 0.170 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2019 | 230 | 0.170 |
Why?
|
| Regeneration | 3 | 2011 | 1498 | 0.170 |
Why?
|
| Disease Progression | 5 | 2021 | 13364 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2021 | 232 | 0.160 |
Why?
|
| Matrix Metalloproteinase 13 | 5 | 2011 | 103 | 0.160 |
Why?
|
| Papillary Muscles | 2 | 2017 | 202 | 0.160 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 433 | 0.160 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 294 | 0.160 |
Why?
|
| Hyperlipidemias | 2 | 2019 | 797 | 0.160 |
Why?
|
| Cell Movement | 8 | 2016 | 5222 | 0.160 |
Why?
|
| Cell Division | 5 | 2004 | 4549 | 0.160 |
Why?
|
| Organic Anion Transporters | 1 | 2019 | 98 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9743 | 0.160 |
Why?
|
| Female | 37 | 2021 | 385090 | 0.160 |
Why?
|
| Mitral Valve Stenosis | 1 | 2020 | 376 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2024 | 1555 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2901 | 0.150 |
Why?
|
| Mesoderm | 3 | 2011 | 685 | 0.150 |
Why?
|
| Muscle, Smooth | 2 | 2004 | 943 | 0.150 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2022 | 881 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2016 | 1680 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2021 | 445 | 0.150 |
Why?
|
| Organ Preservation Solutions | 1 | 2018 | 96 | 0.150 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 1687 | 0.150 |
Why?
|
| Water | 1 | 2024 | 1403 | 0.150 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 390 | 0.150 |
Why?
|
| Time Factors | 12 | 2017 | 40195 | 0.150 |
Why?
|
| Tissue Preservation | 1 | 2018 | 180 | 0.150 |
Why?
|
| Umbilical Veins | 1 | 2018 | 432 | 0.150 |
Why?
|
| Phosphorylation | 4 | 2016 | 8414 | 0.150 |
Why?
|
| Apoptosis | 7 | 2016 | 9657 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 989 | 0.150 |
Why?
|
| Bone Density | 1 | 2010 | 3504 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 1998 | 402 | 0.140 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2017 | 86 | 0.140 |
Why?
|
| Immunohistochemistry | 11 | 2018 | 11395 | 0.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 533 | 0.140 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 421 | 0.140 |
Why?
|
| Mutation | 4 | 2020 | 29981 | 0.140 |
Why?
|
| RNA, Messenger | 9 | 2015 | 13011 | 0.140 |
Why?
|
| Cytokines | 3 | 2021 | 7400 | 0.140 |
Why?
|
| Awards and Prizes | 1 | 2021 | 377 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2016 | 428 | 0.140 |
Why?
|
| Alkaline Phosphatase | 2 | 2019 | 866 | 0.140 |
Why?
|
| Echocardiography | 6 | 2018 | 5117 | 0.140 |
Why?
|
| RNA Interference | 3 | 2016 | 2885 | 0.140 |
Why?
|
| Myocardium | 8 | 2010 | 4719 | 0.140 |
Why?
|
| Atrial Function, Left | 1 | 2017 | 178 | 0.140 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 404 | 0.140 |
Why?
|
| Neutrophil Infiltration | 2 | 2017 | 391 | 0.140 |
Why?
|
| Cell Proliferation | 7 | 2016 | 10508 | 0.140 |
Why?
|
| Tomography, Optical | 2 | 2007 | 130 | 0.140 |
Why?
|
| Actins | 5 | 2016 | 2114 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 3120 | 0.140 |
Why?
|
| Receptors, Notch | 2 | 2019 | 749 | 0.130 |
Why?
|
| Casein Kinase I | 1 | 2016 | 47 | 0.130 |
Why?
|
| Osteoblasts | 3 | 2016 | 1163 | 0.130 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15164 | 0.130 |
Why?
|
| Workflow | 1 | 2020 | 852 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2001 | 133 | 0.130 |
Why?
|
| Diet, Fat-Restricted | 1 | 1998 | 320 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2022 | 1553 | 0.130 |
Why?
|
| Proprotein Convertases | 1 | 2016 | 95 | 0.130 |
Why?
|
| Casein Kinase II | 1 | 2016 | 128 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1368 | 0.130 |
Why?
|
| Smad3 Protein | 1 | 2016 | 182 | 0.130 |
Why?
|
| Losartan | 1 | 2017 | 303 | 0.130 |
Why?
|
| Phospholipids | 1 | 2019 | 785 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 331 | 0.130 |
Why?
|
| Career Choice | 1 | 2021 | 751 | 0.130 |
Why?
|
| Polyglycolic Acid | 3 | 2010 | 408 | 0.130 |
Why?
|
| Tissue Scaffolds | 3 | 2023 | 964 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.130 |
Why?
|
| Endothelium | 2 | 2022 | 779 | 0.130 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2017 | 351 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 1779 | 0.120 |
Why?
|
| Genomics | 2 | 2021 | 5743 | 0.120 |
Why?
|
| Risk Factors | 8 | 2024 | 73094 | 0.120 |
Why?
|
| Cell Survival | 4 | 2016 | 5860 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2016 | 310 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2021 | 2580 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 644 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 248 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2016 | 2499 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1160 | 0.120 |
Why?
|
| Aged | 15 | 2024 | 165629 | 0.120 |
Why?
|
| Stroke | 2 | 2014 | 10152 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 1439 | 0.120 |
Why?
|
| Matrix Metalloproteinase 1 | 3 | 2001 | 140 | 0.120 |
Why?
|
| Osteopontin | 1 | 2015 | 301 | 0.110 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2015 | 179 | 0.110 |
Why?
|
| Bioreactors | 1 | 2005 | 236 | 0.110 |
Why?
|
| Database Management Systems | 1 | 2014 | 269 | 0.110 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2013 | 191 | 0.110 |
Why?
|
| Culture Media | 1 | 2015 | 908 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 1426 | 0.110 |
Why?
|
| Alkynes | 1 | 2013 | 306 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4228 | 0.110 |
Why?
|
| Color | 1 | 2014 | 304 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2018 | 21904 | 0.110 |
Why?
|
| Bone Marrow Cells | 3 | 2013 | 2491 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 691 | 0.110 |
Why?
|
| Amino Acid Sequence | 3 | 2022 | 13778 | 0.110 |
Why?
|
| Fetal Development | 1 | 2018 | 771 | 0.110 |
Why?
|
| Bioartificial Organs | 1 | 2002 | 49 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 276 | 0.110 |
Why?
|
| NF-kappa B | 3 | 2022 | 2495 | 0.110 |
Why?
|
| Swine | 3 | 2021 | 5965 | 0.110 |
Why?
|
| Middle Aged | 17 | 2024 | 216054 | 0.100 |
Why?
|
| Metabolomics | 1 | 2021 | 1529 | 0.100 |
Why?
|
| Wound Healing | 3 | 2008 | 2798 | 0.100 |
Why?
|
| Adiponectin | 1 | 2018 | 1108 | 0.100 |
Why?
|
| Gadolinium DTPA | 3 | 2011 | 835 | 0.100 |
Why?
|
| Drug Design | 1 | 2017 | 1079 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11909 | 0.100 |
Why?
|
| Leukocytes | 2 | 2013 | 2056 | 0.100 |
Why?
|
| Nanostructures | 2 | 2008 | 548 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2021 | 2087 | 0.100 |
Why?
|
| Durapatite | 1 | 2013 | 159 | 0.100 |
Why?
|
| Membrane Lipids | 1 | 2013 | 253 | 0.100 |
Why?
|
| Leadership | 1 | 2021 | 1378 | 0.100 |
Why?
|
| Phosphorus | 1 | 2013 | 337 | 0.100 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 193 | 0.100 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2009 | 541 | 0.100 |
Why?
|
| Serine Endopeptidases | 2 | 2022 | 1084 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 20346 | 0.100 |
Why?
|
| Prognosis | 7 | 2019 | 29264 | 0.100 |
Why?
|
| Fibroblasts | 4 | 2007 | 4160 | 0.100 |
Why?
|
| Gold | 2 | 2021 | 488 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1346 | 0.100 |
Why?
|
| Dependovirus | 1 | 2016 | 702 | 0.100 |
Why?
|
| Factor XIII | 2 | 2008 | 59 | 0.100 |
Why?
|
| Biomedical Engineering | 1 | 2002 | 294 | 0.100 |
Why?
|
| Gelatinases | 1 | 2011 | 93 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2015 | 768 | 0.100 |
Why?
|
| Prothrombin | 1 | 2011 | 194 | 0.100 |
Why?
|
| Blood Vessels | 2 | 2009 | 1127 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1748 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2009 | 1613 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2009 | 1861 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2012 | 475 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15657 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2018 | 3561 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3500 | 0.090 |
Why?
|
| Glycine | 1 | 2013 | 665 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2014 | 8971 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2019 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2023 | 255 | 0.090 |
Why?
|
| Hypochlorous Acid | 1 | 2009 | 15 | 0.090 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 690 | 0.090 |
Why?
|
| Peroxynitrous Acid | 1 | 2009 | 40 | 0.090 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 20 | 0.090 |
Why?
|
| Software | 2 | 2014 | 4460 | 0.090 |
Why?
|
| Annexins | 1 | 2009 | 38 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2022 | 23554 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 2088 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 180 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2007 | 3674 | 0.090 |
Why?
|
| Cytostatic Agents | 1 | 2009 | 9 | 0.090 |
Why?
|
| Carotid Stenosis | 2 | 2017 | 864 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2017 | 2385 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3885 | 0.090 |
Why?
|
| Gene Expression | 2 | 2021 | 7771 | 0.090 |
Why?
|
| Contrast Media | 4 | 2011 | 5338 | 0.090 |
Why?
|
| Pentetic Acid | 1 | 2009 | 211 | 0.090 |
Why?
|
| Protein Binding | 1 | 2022 | 9408 | 0.090 |
Why?
|
| Lymphokines | 1 | 2002 | 945 | 0.090 |
Why?
|
| Indocyanine Green | 1 | 2011 | 240 | 0.090 |
Why?
|
| Heptanoic Acids | 2 | 2009 | 343 | 0.090 |
Why?
|
| Tomography | 2 | 2008 | 398 | 0.080 |
Why?
|
| Models, Cardiovascular | 2 | 2013 | 993 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2017 | 4194 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2016 | 1543 | 0.080 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 1089 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 2010 | 246 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2010 | 3668 | 0.080 |
Why?
|
| Bacteriocins | 1 | 2009 | 90 | 0.080 |
Why?
|
| Lactic Acid | 2 | 2010 | 1148 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 113 | 0.080 |
Why?
|
| Pyridines | 1 | 2001 | 2841 | 0.080 |
Why?
|
| Leukocytosis | 1 | 2010 | 246 | 0.080 |
Why?
|
| RNA | 3 | 2023 | 2778 | 0.080 |
Why?
|
| Proteins | 1 | 2024 | 6093 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 58361 | 0.080 |
Why?
|
| Neointima | 2 | 2021 | 135 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 141 | 0.080 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2008 | 114 | 0.080 |
Why?
|
| Androstenes | 1 | 2009 | 170 | 0.080 |
Why?
|
| Oxazines | 1 | 2009 | 304 | 0.080 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 555 | 0.080 |
Why?
|
| tau Proteins | 1 | 2018 | 1939 | 0.080 |
Why?
|
| Biopsy | 2 | 2017 | 6771 | 0.080 |
Why?
|
| Morphogenesis | 1 | 2011 | 748 | 0.080 |
Why?
|
| Cystatin C | 1 | 2009 | 253 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3686 | 0.080 |
Why?
|
| Iliac Artery | 2 | 2008 | 369 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1181 | 0.080 |
Why?
|
| Retroviridae | 1 | 2010 | 914 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 20026 | 0.070 |
Why?
|
| Coronary Disease | 3 | 2016 | 6083 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2003 | 695 | 0.070 |
Why?
|
| Prodrugs | 1 | 2009 | 266 | 0.070 |
Why?
|
| Biocompatible Materials | 4 | 2023 | 1732 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 491 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 808 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 3 | 2003 | 914 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 475 | 0.070 |
Why?
|
| Endocarditis, Bacterial | 1 | 2011 | 459 | 0.070 |
Why?
|
| Homeostasis | 1 | 2018 | 3343 | 0.070 |
Why?
|
| Aging | 1 | 2006 | 8752 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2022 | 53863 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 3766 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 10469 | 0.070 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2011 | 545 | 0.070 |
Why?
|
| Molecular Probes | 1 | 2008 | 319 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5965 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2019 | 5006 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2016 | 3417 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 842 | 0.070 |
Why?
|
| Connective Tissue Cells | 1 | 2006 | 55 | 0.070 |
Why?
|
| Tissue Distribution | 3 | 2021 | 2335 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6542 | 0.070 |
Why?
|
| Graft Rejection | 3 | 2009 | 4370 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 3626 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2006 | 114 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5552 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2014 | 4216 | 0.070 |
Why?
|
| Transfection | 2 | 2010 | 5882 | 0.070 |
Why?
|
| Heart Transplantation | 3 | 2009 | 3123 | 0.070 |
Why?
|
| Dacarbazine | 1 | 2008 | 567 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 663 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2007 | 209 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2008 | 521 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2013 | 2012 | 0.070 |
Why?
|
| Flow Cytometry | 7 | 2009 | 5974 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 643 | 0.060 |
Why?
|
| Estriol | 1 | 1985 | 53 | 0.060 |
Why?
|
| Sulfatases | 1 | 1985 | 45 | 0.060 |
Why?
|
| Necrosis | 1 | 2009 | 1641 | 0.060 |
Why?
|
| Saphenous Vein | 3 | 2012 | 533 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 854 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 94 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3814 | 0.060 |
Why?
|
| Adult | 12 | 2023 | 216658 | 0.060 |
Why?
|
| Pyrroles | 2 | 2009 | 1145 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 1152 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2080 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 2193 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 4041 | 0.060 |
Why?
|
| Sheep, Domestic | 2 | 2017 | 48 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 425 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2008 | 475 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2015 | 6037 | 0.060 |
Why?
|
| Transplantation, Autologous | 3 | 2018 | 2125 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2017 | 9863 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2005 | 294 | 0.060 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2024 | 48 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 153 | 0.060 |
Why?
|
| Half-Life | 3 | 2009 | 663 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3700 | 0.060 |
Why?
|
| Research | 1 | 2012 | 2001 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 471 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 1066 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2012 | 2087 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 405 | 0.060 |
Why?
|
| Cell Line | 3 | 2013 | 16004 | 0.060 |
Why?
|
| Femur | 1 | 2010 | 1308 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 1919 | 0.060 |
Why?
|
| Peptides | 3 | 2009 | 4430 | 0.060 |
Why?
|
| Creatinine | 1 | 2009 | 1893 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2016 | 3334 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 1972 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 791 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12250 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 1459 | 0.060 |
Why?
|
| Nephrectomy | 1 | 2009 | 1046 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2927 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2010 | 5144 | 0.060 |
Why?
|
| Spleen | 1 | 2009 | 2369 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 672 | 0.050 |
Why?
|
| Cyproheptadine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Magnetics | 1 | 2006 | 605 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 1508 | 0.050 |
Why?
|
| Gadolinium | 1 | 2008 | 959 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2008 | 1211 | 0.050 |
Why?
|
| Subtilisins | 1 | 2022 | 83 | 0.050 |
Why?
|
| Placenta Diseases | 1 | 1985 | 198 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 1636 | 0.050 |
Why?
|
| Heart Failure | 2 | 2021 | 11096 | 0.050 |
Why?
|
| Heart | 2 | 2019 | 4458 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 2015 | 0.050 |
Why?
|
| Fluorescence | 3 | 2011 | 753 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 838 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 587 | 0.050 |
Why?
|
| Logistic Models | 1 | 2017 | 13441 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2881 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 550 | 0.050 |
Why?
|
| Elasticity | 2 | 2013 | 661 | 0.050 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2007 | 512 | 0.050 |
Why?
|
| Fetus | 2 | 2006 | 1889 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7708 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 294 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2012 | 1993 | 0.050 |
Why?
|
| Cell Lineage | 3 | 2016 | 2526 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 13263 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2009 | 5149 | 0.050 |
Why?
|
| Benzoxazoles | 1 | 2021 | 78 | 0.050 |
Why?
|
| Myxoma | 1 | 2001 | 127 | 0.050 |
Why?
|
| Butyrates | 1 | 2021 | 165 | 0.050 |
Why?
|
| Azo Compounds | 1 | 2001 | 113 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 383 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 2033 | 0.050 |
Why?
|
| Procollagen | 1 | 2001 | 186 | 0.050 |
Why?
|
| Registries | 1 | 2016 | 8216 | 0.050 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 14761 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1800 | 0.050 |
Why?
|
| Cell Count | 1 | 2004 | 1856 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2011 | 2888 | 0.050 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 384 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2006 | 3512 | 0.040 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2001 | 194 | 0.040 |
Why?
|
| Factor X | 1 | 1999 | 64 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1795 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2012 | 2987 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 2021 | 294 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2007 | 1411 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16789 | 0.040 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 3715 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 7805 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 835 | 0.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 1185 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2136 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2007 | 2913 | 0.040 |
Why?
|
| Isotretinoin | 1 | 2019 | 114 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5064 | 0.040 |
Why?
|
| Factor VIIa | 1 | 1999 | 101 | 0.040 |
Why?
|
| Cell Death | 1 | 2004 | 1698 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2023 | 12165 | 0.040 |
Why?
|
| Pravastatin | 1 | 2001 | 395 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 21146 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2023 | 743 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 1944 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9439 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2001 | 566 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 1626 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2009 | 640 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 1186 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2001 | 368 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2001 | 550 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 2197 | 0.040 |
Why?
|
| Serotonin | 1 | 2022 | 1034 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5851 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2746 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2776 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3555 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 413 | 0.040 |
Why?
|
| Ribose | 1 | 2016 | 68 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6352 | 0.040 |
Why?
|
| Tretinoin | 1 | 2019 | 528 | 0.040 |
Why?
|
| Coronary Vessels | 3 | 2019 | 3147 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 532 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 625 | 0.030 |
Why?
|
| Cattle | 2 | 2011 | 3926 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2018 | 964 | 0.030 |
Why?
|
| Angiotensin II | 2 | 2009 | 883 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12868 | 0.030 |
Why?
|
| Prosthesis Design | 3 | 2009 | 2127 | 0.030 |
Why?
|
| Clone Cells | 2 | 2006 | 1692 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2016 | 135 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 190 | 0.030 |
Why?
|
| Radiography | 3 | 2013 | 7047 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 9223 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2000 | 1181 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9664 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2927 | 0.030 |
Why?
|
| Neutrophils | 1 | 2007 | 3729 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2644 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 936 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 367 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2000 | 854 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 1355 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 452 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2009 | 1898 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2018 | 25903 | 0.030 |
Why?
|
| Methacrylates | 1 | 2014 | 107 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17635 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2002 | 2068 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 6417 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 1210 | 0.030 |
Why?
|
| Glioma | 1 | 2008 | 3423 | 0.030 |
Why?
|
| Tropoelastin | 1 | 2013 | 29 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2000 | 952 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 609 | 0.030 |
Why?
|
| Nanotechnology | 2 | 2009 | 706 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2005 | 526 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2016 | 1155 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2012 | 3127 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1642 | 0.030 |
Why?
|
| Vimentin | 2 | 2004 | 264 | 0.030 |
Why?
|
| Light | 2 | 2008 | 1332 | 0.030 |
Why?
|
| Indoles | 1 | 2001 | 1839 | 0.030 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 671 | 0.030 |
Why?
|
| Gelatin | 1 | 2014 | 232 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2020 | 5103 | 0.030 |
Why?
|
| Blood Cells | 1 | 2004 | 310 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 202 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 2004 | 346 | 0.030 |
Why?
|
| Coagulase | 1 | 2011 | 54 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2012 | 97 | 0.020 |
Why?
|
| Adolescent | 5 | 2018 | 86713 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 787 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2955 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 426 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2000 | 2152 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 766 | 0.020 |
Why?
|
| Ligands | 2 | 2009 | 3300 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2022 | 78758 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2007 | 4028 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 493 | 0.020 |
Why?
|
| Cell Separation | 2 | 2006 | 1751 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2011 | 325 | 0.020 |
Why?
|
| Graft Survival | 1 | 2021 | 3731 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2011 | 128 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1875 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 737 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2010 | 273 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 314 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2023 | 64017 | 0.020 |
Why?
|
| Reactive Nitrogen Species | 1 | 2009 | 36 | 0.020 |
Why?
|
| Microcirculation | 1 | 2004 | 1307 | 0.020 |
Why?
|
| Stents | 1 | 2021 | 3311 | 0.020 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2009 | 59 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 2009 | 142 | 0.020 |
Why?
|
| Endocardium | 1 | 2010 | 264 | 0.020 |
Why?
|
| Iopamidol | 1 | 2009 | 191 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2010 | 246 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 2152 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2010 | 2287 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 2009 | 257 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 2739 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 2009 | 177 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 880 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 424 | 0.020 |
Why?
|
| Infant | 2 | 2006 | 35447 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2008 | 81 | 0.020 |
Why?
|
| Ear | 1 | 2009 | 173 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6169 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2008 | 49 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2009 | 4794 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 10256 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 1074 | 0.020 |
Why?
|
| Peritoneum | 1 | 2009 | 227 | 0.020 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2008 | 49 | 0.020 |
Why?
|
| Dalteparin | 1 | 2008 | 43 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2005 | 799 | 0.020 |
Why?
|
| Anisotropy | 1 | 2011 | 1280 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 1156 | 0.020 |
Why?
|
| Clinical Enzyme Tests | 1 | 2008 | 115 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2006 | 41390 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2010 | 363 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2009 | 719 | 0.020 |
Why?
|
| Splenectomy | 1 | 2009 | 395 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2004 | 1332 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1432 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 1586 | 0.020 |
Why?
|
| Rupture | 1 | 1999 | 434 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2011 | 546 | 0.020 |
Why?
|
| Granulation Tissue | 1 | 2007 | 94 | 0.020 |
Why?
|
| Copper Radioisotopes | 1 | 2007 | 88 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2011 | 805 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2007 | 68 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 639 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 8947 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 428 | 0.020 |
Why?
|
| Phagocytes | 1 | 2009 | 297 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 750 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 864 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2011 | 788 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2426 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 301 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 225 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 496 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 925 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 677 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2009 | 424 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6954 | 0.020 |
Why?
|
| Foreign-Body Reaction | 1 | 2007 | 157 | 0.020 |
Why?
|
| Endocytosis | 1 | 2011 | 987 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1766 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2007 | 446 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2007 | 294 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2004 | 2253 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1830 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1569 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3111 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1604 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2006 | 76 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 736 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1906 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1182 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1773 | 0.020 |
Why?
|
| Adipocytes | 1 | 2012 | 1193 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 240 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 1526 | 0.020 |
Why?
|
| Ichthyosis | 1 | 1985 | 60 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2006 | 318 | 0.020 |
Why?
|
| Ephrin-B2 | 1 | 2004 | 39 | 0.020 |
Why?
|
| Child | 3 | 2006 | 78594 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2008 | 621 | 0.020 |
Why?
|
| Photons | 1 | 2008 | 589 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2008 | 693 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 215 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12423 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2730 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2008 | 654 | 0.010 |
Why?
|
| Particle Size | 1 | 2008 | 1648 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 1276 | 0.010 |
Why?
|
| Antioxidants | 1 | 2012 | 1669 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1985 | 184 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 438 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 12970 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3761 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1467 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1995 | 15459 | 0.010 |
Why?
|
| Myosins | 1 | 2004 | 408 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1101 | 0.010 |
Why?
|
| Rats | 2 | 2009 | 24248 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1995 | 785 | 0.010 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
| Phenyl Ethers | 1 | 2002 | 61 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18460 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13044 | 0.010 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2002 | 77 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1812 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2002 | 210 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 455 | 0.010 |
Why?
|
| Veins | 1 | 1995 | 771 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3572 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 1447 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2000 | 92 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2471 | 0.010 |
Why?
|
| Cerebellum | 1 | 2008 | 1498 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 1205 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2002 | 525 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2006 | 945 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2485 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4562 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1995 | 1848 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 571 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5858 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 148 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2561 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 6482 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1395 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 18050 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2423 | 0.010 |
Why?
|
| Microglia | 1 | 2008 | 1291 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 3753 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 57267 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 240 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2987 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39223 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 1621 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 9300 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3889 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8285 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 29630 | 0.010 |
Why?
|
| Simvastatin | 1 | 2000 | 362 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8199 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3586 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40939 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 7312 | 0.010 |
Why?
|
| Placenta | 1 | 1985 | 1725 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 4598 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4403 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 3118 | 0.010 |
Why?
|
| Biological Products | 1 | 2002 | 881 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2008 | 4738 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 3035 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 26598 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 2748 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 9990 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2002 | 3845 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 12802 | 0.000 |
Why?
|
| United States | 1 | 2011 | 70772 | 0.000 |
Why?
|